Last reviewed · How we verify
NCT06753812
Investigation of the Effect of Constraint Induced Movement Therapy Applied to the Lower Extremity on Lower Extremity Functions in Individuals With Unilateral Cerebral Palsy
NA trial testing constraint induced movement therapy in Cerebral Palsy Spastic Hemiplegic in 36 participants. Enrolling by invitation.
30 May 2025
Quick facts
| Lead sponsor | Abant Izzet Baysal University |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 15 January 2025 |
| Primary completion | 30 May 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- constraint induced movement therapy
- Control (Standard treatment) — full drug profile →
Conditions studied
- Cerebral Palsy Spastic Hemiplegic — all drugs for Cerebral Palsy Spastic Hemiplegic →
Sponsor
Abant Izzet Baysal University
Who can join
Adults 5 to 15, any sex, with Cerebral Palsy Spastic Hemiplegic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Lower extremity constraint induced movement therapy has been applied to individuals with multiple sclerosis, stroke, subacute and chronic hemiparesis in recent years and positive results have been reported. However, there is no study in the literature regarding the application of this treatment method to the pediatric population. In order to address this gap in the literature, we planned to conduct this study to examine the possible effects of lower extremity constraint induced movement therapy on lower extremity functions, balance and gait parameters in individuals with cerebral palsy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06753812
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of constraint induced movement therapy
Trials testing the same drug.
- NCT06708273 — Effect of Constraint Induced Movement Therapy on Burned Dominant Hand Function · NA · completed
- NCT05490758 — Sensorimotor Training and Constraint Induced Movement Therapy on Upper Extremity Function in Children With Hemiplegic CP · NA · completed
Other recruiting trials for Cerebral Palsy Spastic Hemiplegic
Currently open trials in the same condition.
- NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
Other Abant Izzet Baysal University trials
Trials by the same sponsor.
- NCT07374744 — Effect of Interactive Video-Based Self-Management Education in Adults With Type 2 Diabetes · NA · not yet recruiting
- NCT07524790 — The Effect of Proprioceptive Neuromuscular Facilitation on Haemodynamic Responses in a Neurological Intensive Care · NA · not yet recruiting
- NCT07507721 — Tele-Nursing-Supported Mindfetalness: Anxiety and Prenatal Attachment · NA · not yet recruiting
- NCT07509021 — Neuropathic Pain, Catastrophizing, and Adherence in SAIS · recruiting
- NCT07535177 — Gas6 and Soluble MerTK in Periodontal Diseases · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06753812 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Abant Izzet Baysal University
- Last refreshed: 31 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06753812.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing